Lava Therapeutics N.V. is a biopharmaceutical company focused on developing innovative therapies for cancer treatment

The company specializes in its unique platform technology aimed at harnessing the power of gamma delta T cells, a type of immune cell that plays a significant role in the body’s defense against tumors. By creating novel immune-oncology treatments, Lava Therapeutics strives to improve patient outcomes and provide more effective options for those battling various forms of cancer. Through rigorous research and development, the company seeks to advance its product pipeline and bring new therapies to market, aiming to address unmet medical needs in the oncology space.